Prior to joining the Office of Tech Transfer, Allison was a Senior Writer at BioCentury, where she performed in-depth analyses of hot topics and trends in the biopharma industry. Her work spanned therapeutic modalities and disease areas from preclinical development through FDA approval.
Allison holds a Ph.D. in Molecular and Cellular Pathology from the University of Michigan, and a B.S. in Biochemistry from Juniata College.